Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • Eleven Minutes
    • Priced Out
    • Data Grab
    • Memory Gaps
    • Growing Up Scared
    • Denied
    • Opioid Settlement Tracking
    • Guns, Race, and Profit
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email
  • Add Us to Google

Tuesday, Nov 17 2026 8:58 AM

Full Issue

Powers Takes Permanent Helm At NIAID, Vows Return To 'Primary Mission' Of Studying Diseases

John Powers III will fill the role once long held by Dr. Anthony Fauci. "Our remit is to conduct, support research, and disseminate scientific information related to infectious, allergic, and autoimmune diseases," he said of the National Institute of Allergy and Infectious Diseases. Gain-of-function research is not part of that job, he said. Plus, the latest about comptroller general and FDA nominations.

Stat: John Powers III Appointed Permanent Director Of NIAID 

The acting director of the National Institute of Allergy and Infectious Diseases, John Powers III, will become the permanent director, the agency announced Monday. (Oza, 11/16)

The Washington Post: Trump Nominates Eric Ueland As Comptroller General 

President Donald Trump has nominated Eric Ueland to serve as the next comptroller general of the United States, a key watchdog role that audits and investigates federal spending across government agencies. The nomination to head the Government Accountability Office is for a 15-year term, which means it will extend well into the next presidency. (Cook and Alfaro, 11/7)

The Washington Post: White House Weighs Next Steps For FDA Nominee Who Faces Bipartisan Pushback 

Some Trump administration officials are growing skeptical that the Senate will confirm Heidi Overton to lead the Food and Drug Administration, prompting them to discuss whether to attempt to shore up her nomination or abandon it altogether, according to four people familiar with the matter who spoke on the condition of anonymity to discuss a personnel matter. (Roubein and Diamond, 11/16)

More Trump administration news —

Stat: In A Win For MAHA, FDA Creates New Regulatory Category For The Supplement NAC

The Food and Drug Administration is proposing a new classification for a product that’s existed in a legal gray area for years, a win for proponents of dietary supplements, including members of the MAHA movement. (Manto, 11/16)

Stat: RFK Jr. Pushes Federal Funding For Faith-Based Recovery Organizations 

While campaigning the week before the midterms, health secretary Robert F. Kennedy Jr. visited Sheepgate, a Christian addiction recovery center in Colfax, Iowa. Sheepgate, Kennedy said, is a model for the type of faith-based center that doesn’t receive federal funding but that he believes should. (Gaffney, 11/17)

The New York Times: American Global Health Aid Isn’t Dead. It’s Changing

Americans might have assumed that their country was out of the business of promoting global health. On his first day in office, President Trump announced the United States’ withdrawal from the World Health Organization and abruptly “paused” foreign aid. Over the following weeks, Elon Musk took a chain saw to the U.S. Agency for International Development. In the wake of these actions, reporters documented shortages of tuberculosis, malaria and H.I.V. drugs, widespread clinic closures and the abandonment of patients enrolled in medical trials. Many programs never resumed, and researchers predicted that hundreds of thousands of avoidable deaths would occur in the first year alone. (Fink, 11/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, November 17
  • Monday, November 16
  • Friday, November 13
  • Thursday, November 12
  • Tuesday, November 10
  • Friday, November 6
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF